Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry Letters|April 11, 2008
Novel 2-imidazoles as potent and selective alpha1A adrenoceptor partial agonistsGavin A Whitlock, Kelly Conlon, Gordon McMurray, et al.Bioorganic & Medicinal Chemistry Letters|June 6, 2006
Structure-activity relationships of N-substituted piperazine amine reuptake inhibitorsM Jonathan Fray, Gerwyn Bish, Paul V Fish, et al.Bioorganic & Medicinal Chemistry Letters|April 11, 2009
4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationshipsPaul V Fish, Mark D Andrews, M Jonathan Fray, et al.Bioorganic & Medicinal Chemistry Letters|July 16, 2008
N-Benzyl-N-(pyrrolidin-3-yl)carboxamides as a new class of selective dual serotonin/noradrenaline reuptake inhibitorsFlorian Wakenhut, Paul V Fish, M Jonathan Fray, et al.Bioorganic & Medicinal Chemistry Letters|June 6, 2006
N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitorM Jonathan Fray, Gerwyn Bish, Alan D Brown, et al.Bioorganic & Medicinal Chemistry Letters|July 16, 2008
Derivatives of (3S)-N-(biphenyl-2-ylmethyl)pyrrolidin-3-amine as selective noradrenaline reuptake inhibitors: Reducing P-gp mediated efflux by modulation of H-bond acceptor capacityPaul V Fish, Nancy S Barta, David L F Gray, et al.ACS Chemical Biology|November 1, 2016
Quantitative Chemical Proteomic Profiling of Ubiquitin Specific Proteases in Intact Cancer CellsJennifer A Ward, Lauren McLellan, Martin Stockley, et al.Bioorganic & Medicinal Chemistry Letters|April 5, 2008
Design and synthesis of morpholine derivatives. SAR for dual serotonin & noradrenaline reuptake inhibitionPaul V Fish, Christopher Deur, Xinmin Gan, et al.Bioorganic & Medicinal Chemistry Letters|August 4, 2009
N-[(3S)-Pyrrolidin-3-yl]benzamides as novel dual serotonin and noradrenaline reuptake inhibitors: impact of small structural modifications on P-gp recognition and CNS penetrationFlorian Wakenhut, Gill A Allan, Paul V Fish, et al.Chemical Biology & Drug Design|July 5, 2012
Identification of type-II inhibitors using kinase structuresFrank Lovering, Joseph McDonald, Gavin A Whitlock, et al.Pageof 3